Qualcomm Life, Inc.

5775 Morehouse Drive , 92121 San Diego, CA
USA

Telephone +1 858 8451033
qualcommlife@qti.qualcomm.com

Trade fair hall

  • Hall 15 / A19
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 15): stand A19

Fairground map

MEDICA 2016 fairground map: Hall 15

Our range of products

Product categories

  • 06  Information and communication technology
  • 06.03  eHealth, telemedicine / telematics / telemetry

Our products

Product category: eHealth, telemedicine / telematics / telemetry

2net Platform

2net Platform

  • The 2net Platform is a scalable, cloud-based system that enables end-to-end medical device data connectivity, transmission and integration with virtually any system, application or portal.
  • 2net Platform is an FDA-listed, Class 1 MDDS and CE-marked Class 1 Medical Device (EU) enterprise-grade infrastructure, enabling secure sharing and storage of vital data 

More Less

Product category: eHealth, telemedicine / telematics / telemetry

2net Hub

The 2net Hub is a plug-and-play communications device that enables highly secure, medical-grade connectivity and an effortless user experience. The 2net Hub integrates with wide- and short- range radios, and offers flexible connectivity across a growing and open ecosystem of medical devices and sensors.

More Less

Product category: eHealth, telemedicine / telematics / telemetry

2net Mobile

2net Mobile is a medical-grade software module that can be embedded in third-party mobile applications. It transforms mobile computing devices, smartphones and tablets into secure medical- grade gateways that capture, transmit and protect data for patients at home or on-the-go

More Less

Product category: eHealth, telemedicine / telematics / telemetry

Capsule™ Medical Device Information System

The Capsule Platform delivers comprehensive medical device integration and clinical data management across the hospital enterprise. An industry leading Medical Device Information System (MDIS), Capsule connects, integrates and analyzes data into the EMR and other intelligent enterprise systems helping enhance clinical workflows and improve operational efficiencies. Capsule provides:

  • One of the largest dynamic libraries of medical device driver interfaces (DDIs), with over 770 drivers that read and translate device protocols
  • Four enterprise connectivity options and integration with 48 major EMR’s and Health IT systems offering customers flexibility to meet virtually any connectivity need
  • Accurately charts vitals and other patient-specific information to add accuracy and simplicity to clinical workflows
  • Single-screen charting of configurable vital signs and modifiers to speed data entry and further streamline workflows
  • Analytic tools and an Early Warning Scoring System (EWSS) help clinicians better recognize signs of deterioration and make appropriate interventions

More Less

Product category: eHealth, telemedicine / telematics / telemetry

2net Design

Powering the next generation of therapies and medical devices, 2net Design services offer turnkey low-power connectivity solutions and technology licensing. These integrated, wireless reference designs allow companies to securely and rapidly deploy connected health solutions.

More Less

Company news

Date

Topic

Download

Oct 31, 2016

MEDTRONIC AND QUALCOMM COLLABORATE TO AIM TO IMPROVE CARE AND HEALTH OUTCOMES FOR PEOPLE WITH TYPE 2 DIABETES

FOR IMMEDIATE RELEASE

 

MEDTRONIC AND QUALCOMM COLLABORATE TO AIM TO IMPROVE CARE AND HEALTH OUTCOMES FOR PEOPLE WITH TYPE 2 DIABETES

 

 Joint Development of Future Generation Continuous Glucose Monitoring (CGM) Systems Aims to Provide Actionable Insights to Help Deliver Integrated Diabetes Care

 

DUBLIN and SAN DIEGO – May 25, 2016 – Medtronic plc (NYSE:MDT) and Qualcomm Incorporated (NASDAQ:QCOM) through its wholly-owned subsidiary, Qualcomm Life, Inc., today announced a global, multi-year collaboration to jointly develop future generation continuous glucose monitoring (CGM) systems that aim to improve health outcomes for people with diabetes. By giving insights to doctors and people with type 2 diabetes concerning glucose levels, the companies intend to enable more informed care, especially for those who do not have control of their diabetes today. The collaboration seeks to leverage Medtronic’s market-leadership in diabetes management and Qualcomm Life’s expertise in developing reference designs for wireless, single-use and small integrated modules to create more affordable, easier-to-use CGM systems, including a new sensor and smaller design that can provide near real-time and retrospective glucose data.

 

The initial focus of the collaboration will be to develop a single-use CGM system designed for broader practice by general practitioners who manage care for the vast majority of the 400 million people worldwide with type 2 diabetes. This collaboration supports Medtronic's strategy to develop comprehensive CGM solutions that not only measure glucose but enable the delivery of actionable insights to both patients and providers. 

 

Leveraging Qualcomm Life’s deep wireless expertise and technologies, 2net™ Design is a platform for designing the communications components of connected medical devices, including disposable drug delivery devices and disposable diagnostic devices for condition specific connected therapies.

 

“We believe that glucose should be a vital sign of diabetes health. Professional CGM is an increasingly used diagnostic tool that empowers physicians and patients with meaningful glucose data to tackle glucose control. Our solutions go beyond delivering data and provide automated observations and clinical decision support to help create a personalized care plan,” said Laura Stoltenberg, vice president and general manager, Non-Intensive Diabetes Therapies at Medtronic. “Our vision is to transform diabetes care so people with diabetes can enjoy greater freedom and better health. We are thrilled to be collaborating with Qualcomm Life - a best-in-class leader in wireless technologies that is ahead of the curve in a rapidly changing connected world - to develop innovative and affordable CGM systems that will fundamentally change type 2 diabetes management.”

 

“Qualcomm Life’s connected health expertise along with our enabling 2net Connectivity Platform and 2net Design capabilities fit naturally with Medtronic’s diabetes leadership in bringing future generation CGM systems to market,” said Rick Valencia, president and general manager, Qualcomm Life, Inc. “This collaboration furthers our commitment of enabling new connected care models that liberate vital data and unlock insights to deliver intelligent care wherever the patient may be.”

 

Advanced CGM solutions are a critical element of an integrated care model. By building an ecosystem of industry leading partners, Medtronic aims to deliver more than just devices and provide intelligent solutions that improve outcomes, while lowering the overall cost of care.

 

About Qualcomm Incorporated

Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

 

About the Diabetes Group at Medtronic (www.medtronicdiabetes.com)

Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.

 

About Medtronic

Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

 

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

 

Qualcomm and 2net are trademarks of Qualcomm Incorporated, registered in the United States and other countries, used with permission.

 

 

-end-

More Less

Aug 31, 2016

Philips and Qualcomm announce strategic collaboration to advance personalized connected health care

  • Philips HealthSuite to serve as a global, secure data storage solution for Qualcomm Life’s medical-grade 2netTM Platform 
  • Qualcomm Life’s 2net Platform to provide medical-grade connectivity and integration for Philips and third-party medical devices for Philips HealthSuite connected care solutions and services 
Amsterdam, The Netherlands and San Diego, CA – Royal Philips (NYSE: PHG; AEX: PHIA) and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., today announced a strategic technology collaboration to advance connected health across the health continuum -- from healthy living and prevention to chronic care management and home care. The companies are teaming up to leverage each other’s respective leading capabilities – Philips’ leadership in connected health informatics and regulated health care cloud data management and analytics, and Qualcomm Life’s expertise in secure, medical-grade device connectivity and integration. This collaboration will enable both companies to offer care providers enhanced, scalable, connected care solutions and services within a secure global ecosystem.

Qualcomm Life’s 2net Platform will serve as the medical device connectivity solution for Philips HealthSuite, the company’s cloud-enabled health ecosystem of devices, apps and digital tools. By joining the Qualcomm Life 2net Ecosystem, Philips provides its HealthSuite users seamless access to a wide array of connected medical devices including medication dispensers, medical grade biosensors, ventilators, blood pressure monitors, point of care self-tests, and blood glucose meters. Philips will leverage the 2net Platform to connect both Philips and third party medical devices. Secure connectivity, data capture and transmission powered by the 2net Platform, 2net Hub and 2net Mobile, will enable HealthSuite users to customize and scale connected care programs, add additional medical devices and gain a fuller patient profile over longer periods of time, with the aim to support timely intervention, assist in diagnosis, personalize treatment plans and help contribute to the goal of improving patient outcomes. An example of an implementation of this connectivity collaboration will go live shortly with Philips’ Trilogy ventilator family and Care Orchestrator care management application to advance care for patients with COPD and other respiratory conditions.

As part of the collaboration, Qualcomm Life will leverage Philips HealthSuite as a global, secure, data management and storage solution for its medical-grade 2net Platform, allowing Qualcomm Life to tap into the value of health data through data normalization, aggregation and analytics. Qualcomm Life customers can now have direct access to build applications, integrate with electronic health
August 31, 2016

record systems, store normalized data, run analytics, and manage authorization and consents in a compliant and secure environment.

“As the home is fast becoming a viable care setting, care providers, home health agencies, and other institutions are increasingly using connected care to reduce emergency care, readmissions of patients with chronic diseases,” said Jeroen Tas, CEO, Connected Care and Health Informatics at Philips. “By collaborating with Qualcomm Life and leveraging its connectivity and wireless expertise, we aim to help care providers to engage better with their patients and contribute to the goal of improving outcomes. Patient self-management combined with 24/7 connectivity to a care network is an emerging model that enables scalable chronic disease management for patients and providers.”

“An undeniable leader in the health care technology industry, Philips brings a deep technology expertise to their health care initiatives, and by joining forces we aim to deliver intelligent care to patients and providers at scale,” said Rick Valencia, president, Qualcomm Life, Inc. “We are thrilled to be working with Philips, enabling Qualcomm Life to continue to grow its ecosystem and ultimately serve as the underpinning of the Internet of Medical Things.”

Jeroen Tas and Rick Valencia will deliver keynote presentations at Qualcomm Life’s connected health ecosystem conference, Connect 2016, on August 31, in San Diego, CA. For more information please visit http://www.qualcommlife.com/connect/ and follow @PhilipsLiveFrom, @QualcommLife and the event hashtag, #qualcommconnect.

For more information on Philips HealthSuite, please visit: http://www.usa.philips.com/healthcare/innovation/about-health-suite.
For more information on Qualcomm Life 2net, please visit: http://www.qualcommlife.com/mobile- medical-solutions.

More Less

Aug 30, 2016

Qualcomm and Boehringer Ingelheim Pharmaceuticals collaborate to add new digital technology to RESPIMAT® inhaler

Qualcomm and Boehringer Ingelheim Pharmaceuticals collaborate to add new digital technology to RESPIMAT® inhaler

-- Two industry leaders combine strengths in health care and technology to aim to improve chronic obstructive pulmonary disease (COPD) care –

SAN DIEGO, CALIFORNIA AND RIDGEFIELD, CONNECTICUT — August 30, 2016 —

Boehringer Ingelheim Pharmaceuticals Inc. and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., today announced a new collaboration to develop a connectivity solution for the RESPIMAT inhaler, the platform inhaler for the Boehringer Ingelheim family of respiratory therapies, to help improve COPD treatment outcomes. The collaboration will be announced at Qualcomm Life’s fifth annual Connect 2016 ecosystem conference, taking place on August 30 and August 31, 2016 in San Diego, California.

“For more than 40 years, Boehringer Ingelheim has had an unwavering commitment to the COPD community to provide new health solutions that can help improve patient outcomes and expand our understanding of COPD,” said Ruchin Kansal, Executive Director and Head, Business Innovation, Boehringer Ingelheim Pharmaceuticals, Inc. “Boehringer Ingelheim is proud to join forces with Qualcomm Life, a global leader in wireless technologies, to bring the latest technology to our RESPIMAT inhaler with the goal of improving adherence to daily medicines that treat symptoms of COPD.”

“Qualcomm Life is committed to powering the Internet of Medical Things to ultimately enable intelligent care to be delivered wherever the patient may be,” said Rick Valencia, president, Qualcomm Life, Inc. “We are excited to be collaborating with an industry leader like Boehringer Ingelheim to deliver a more seamless digital health experience that can enable their COPD patients to better manage their disease.”

Through its 2netTM* Design platform, Qualcomm Life is developing the prototype for a small, wireless, low-power, disposable module for the RESPIMAT inhaler. This fully-integrated inhaler, which is designed to seamlessly connect with Qualcomm Life’s 2net Platform, will be able to track puffs from the RESPIMAT inhaler, and the collected information can be shared with health care providers and people who have been prescribed one of Boehringer Ingelheim’s RESPIMAT medicines.

As with other chronic diseases, poor adherence to treatment plans is common among people with COPD and can result in increased rates of COPD symptoms, health care costs, hospitalizations and even death. The collaboration seeks to combine Boehringer Ingelheim’s global leadership in discovering and developing COPD medicines with Qualcomm Life’s expertise in developing reference designs for wireless, single-use and small integrated modules to create a solution to support adherence to daily treatment regimens.

The RESPIMAT is the platform inhaler for the Boehringer Ingelheim respiratory medications. For more information about the RESPIMAT inhaler and the medicines approved for use in the RESPIMAT, please visit www.us.respimat.com.

Leveraging Qualcomm Life’s deep wireless expertise and technologies, 2net Design is a platform for designing the communications components of connected medical devices, including disposable drug delivery devices and disposable diagnostic devices for condition specific connected therapies.

About Connect 2016

Sponsored by Lenovo Health, UnitedHealthcare, Amazon Web Services, EVRY USA, Striiv, Olumia Life, and GlobalLogic, Connect 2016 brings together connected health industry leaders for an engaging knowledge exchange on cutting edge topics including security, unlocking data and insights to power intelligent care, and a seamless care continuum. For updates and to join real-time conversations from Connect 2016, follow @qualcommlife and #qualcommconnect on Twitter and visit our YouTube channel to view the presentations.

About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with 145 affiliates and more than 47,000 employees. Since its founding in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine.

Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. To learn more about how we make more health for more people, visit our Corporate Social Responsibility Report.

In 2015, Boehringer Ingelheim achieved net sales of about $15.8 billion
(14.8 billion euros). R&D expenditure corresponds to 20.3 percent of its net sales.

For more information please visit www.us.boehringer-ingelheim.com, or follow us on Twitter @BoehringerUS.

About Qualcomm Incorporated

Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information,
PC-COPD-0164-CONS
entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

* 2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries.

More Less

Jun 16, 2016

Hill-Rom Introduces The VisiVestTM System, the World’s First Connected Airway Clearance System

Hill-Rom Introduces The VisiVestTM System, the World’s First Connected Airway Clearance System

— System designed to build stronger connections between patients and care teams to help improve therapy adherence —

CHICAGO, June 16, 2016 – Hill-Rom Holdings, Inc. (NYSE: HRC), a leading global medical technology company, today announced the introduction of the VisiVest System, a connected therapeutic solution for patients in need of airway clearance therapy. The world’s first solution combining industry-leading high-frequency chest-wall oscillation (HFCWO) technology with wireless connectivity powered by Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated, the VisiVest System provides therapy adherence data that may help inform decisions caregivers make for their patients, resulting in reduced risk of respiratory infections, hospitalizations, and medical costs.

 

Patients’ usage data from the VisiVest System is remotely and securely transmitted to the VisiView™ Health Portal via Qualcomm Life’s 2net™ Hub enabling highly secure, medical-grade connectivity and effortless user experience. The VisiView Health Portal, developed by Razorfish, a leading application development company, then displays data trends in an easy-to-use dashboard format. This connectivity fosters a closer partnership between patients and health care teams, so treatment decisions by caregivers can be more tailored and responsive, which may result in better therapy adherence. 

 

“In healthcare, the ability to make decisions based on accurate, timely information is essential,” said Alton Shader, president, Front Line Care at Hill-Rom. “The VisiVest System and Qualcomm Life’s 2net connectivity solution bring care teams and patients closer, helping to better manage patients’ illness and improve their quality of life.”

 

“We are thrilled to be working with a global industry leader in health care technology and excited by the impact our collaboration with Hill-Rom can have for chronic lung disease patients and their caregivers,” said Rick Valencia, president, Qualcomm Life, Inc. “By combining Hill-Rom’s leadership in health care with Qualcomm Life’s expertise in connectivity, we are innovating to deliver effortless connected experiences that empower patients and their care providers.”

 

In a pilot study conducted over the past few months, 160 patients from seven cystic fibrosis clinics have adopted The VisiVest System. Patients and care teams have responded with great enthusiasm and excitement for the technology. 

 

“What I like most about the VisiVest System is being able to see my patients’ session data and trends,” said Tom Newton, pulmonary therapist, Miller Children’s Hospital, Long Beach, CA. “Now I’m not just telling my patients the more adherent they are to their therapy, the higher their pulmonary function numbers are likely to be. We can actually look at their adherence score together and have a more comprehensive conversation about their numbers.”

 

Connected health solutions will continue to strengthen Hill-Rom’s leadership role in the respiratory care industry.

 

The VisiVest™ System

Hill-Rom’s VisiVest garment provides airway clearance by inflating and deflating rapidly, applying gentle pressure to the chest wall. This works to loosen and dislodge mucus from the bronchial walls and move it to larger airways where it can be cleared by coughing or suctioning. If not removed, retained secretions may contribute to increased rates of respiratory infection, hospitalization and reduced lung function.

 

The VisiView™ Health Portal

The VisiView Health Portal is Hill-Rom’s first digital health product designed to enhance communication between health care teams and patients. The VisiView Portal is a secure, cloud-based system that automatically receives information from respiratory care devices in a patient’s home. Patients and health care teams share a user-friendly dashboard to view therapy data and trends for enhanced teamwork.

 

About Hill-Rom Holdings, Inc.

Hill-Rom is a leading global medical technology company with approximately 10,000 employees worldwide. Hill-Rom partners with health care providers in more than 100 countries by focusing on patient- care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. Around the world, Hill-Rom's people, products, and programs work towards one mission: Enhancing outcomes for patients and their caregivers.

 

 

2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries. 2net is a product of Qualcomm Life, Inc.

More Less

About us

Company details

The industry leader in connected health, Qualcomm Life is creating a world where medical-grade care is ‘always on’ and available to patients, regardless of care setting.

Qualcomm Life’s 2net™ and Capsule Platforms capture, connect, integrate and analyze data into hospital EMR and other enterprise systems, enabling rapid and secure data management to help enhance clinical workflows, improve operational efficiencies, and enable informed interventions across the care continuum. Our medical-grade platforms and expansive open ecosystem enable leading health care companies to scale their solutions and realize the benefits of secure, near real-time patient and consumer data. Our rich heritage in mobile and digital helps these companies future-proof their roadmaps and envision new connected health opportunities for next-generation products and therapies.

From hospital to home and all points in between, Qualcomm Life is powering new standards of connected and personalized patient-centered care.

Qualcomm Life, Inc. is  a wholly-owned subsidiary of Qualcomm Incorporated (NASDAQ: QCOM), a world leader in 3G, 4G and next-generation wireless technologies. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other.

www.qualcommlife.com

More Less

Company data

Area of business

Information and Communication Technology

Company information as a PDF file